Advisory
Stanford Law School
Stanford Law’s Michelle Mello discussed the regulatory challenges surrounding AI in healthcare, focusing on gaps in accountability, accuracy, and oversight. As AI tools become more integrated into clinical settings, unresolved questions about liability and patient safety pose significant risks for institutions and patients alike.
Stanford’s active role in these discussions positions it as a thought leader in shaping ethical and legal frameworks for emerging technologies in healthcare. This aligns with its broader mission to influence policy and ensure responsible innovation.
Investment implication: AI regulation will directly impact Stanford’s healthcare and research initiatives. Proactively shaping these policies can mitigate risks and reinforce Stanford’s leadership in ethical healthcare innovation.